Main variables;Fields of operation;Total
Companies that perform R+D in Biotechnology;Total 2019;1.399
Companies that perform R+D in Biotechnology;Companies;1.198
Companies that perform R+D in Biotechnology;P.A.;122
Companies that perform R+D in Biotechnology;Higher Education;66
Companies that perform R+D in Biotechnology;PNPI;13
%Companies according to biotechnology used: Genetic code;Total 2019;40,8
%Companies according to biotechnology used: Genetic code;Companies;33,3
%Companies according to biotechnology used: Genetic code;P.A.;88,5
%Companies according to biotechnology used: Genetic code;Higher Education;87,9
%Companies according to biotechnology used: Genetic code;PNPI;38,5
%Companies according to biotechnology used: Functional Companies;Total 2019;46,7
%Companies according to biotechnology used: Functional Companies;Companies;39,8
%Companies according to biotechnology used: Functional Companies;P.A.;88,5
%Companies according to biotechnology used: Functional Companies;Higher Education;92,4
%Companies according to biotechnology used: Functional Companies;PNPI;53,8
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Total 2019;31,5
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Companies;24,2
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;P.A.;73
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Higher Education;83,3
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;PNPI;53,8
%Companies according to biotechnology used: Bioprocesses;Total 2019;52,4
%Companies according to biotechnology used: Bioprocesses;Companies;49,6
%Companies according to biotechnology used: Bioprocesses;P.A.;59
%Companies according to biotechnology used: Bioprocesses;Higher Education;92,4
%Companies according to biotechnology used: Bioprocesses;PNPI;46,2
%Companies according to biotechnology used: Sub-cellular organisms;Total 2019;14,4
%Companies according to biotechnology used: Sub-cellular organisms;Companies;6,7
%Companies according to biotechnology used: Sub-cellular organisms;P.A.;56,6
%Companies according to biotechnology used: Sub-cellular organisms;Higher Education;72,7
%Companies according to biotechnology used: Sub-cellular organisms;PNPI;38,5
%Companies according to biotechnology used: Bio-computing;Total 2019;30,8
%Companies according to biotechnology used: Bio-computing;Companies;23,9
%Companies according to biotechnology used: Bio-computing;P.A.;71,3
%Companies according to biotechnology used: Bio-computing;Higher Education;84,8
%Companies according to biotechnology used: Bio-computing;PNPI;15,4
%Companies according to biotechnology used: Nanobiotechnology;Total 2019;17,4
%Companies according to biotechnology used: Nanobiotechnology;Companies;11,2
%Companies according to biotechnology used: Nanobiotechnology;P.A.;50,8
%Companies according to biotechnology used: Nanobiotechnology;Higher Education;71,2
%Companies according to biotechnology used: Nanobiotechnology;PNPI;7,7
%Companies according to biotechnology used: Other;Total 2019;13,9
%Companies according to biotechnology used: Other;Companies;14,6
%Companies according to biotechnology used: Other;P.A.;7,4
%Companies according to biotechnology used: Other;Higher Education;15,2
%Companies according to biotechnology used: Other;PNPI;7,7
Companies in which biotechnology activities are:  Main and/or exclusive;Total 2019;685
Companies in which biotechnology activities are:  Main and/or exclusive;Companies;644
Companies in which biotechnology activities are:  Main and/or exclusive;P.A.;33
Companies in which biotechnology activities are:  Main and/or exclusive;Higher Education;2
Companies in which biotechnology activities are:  Main and/or exclusive;PNPI;6
Companies in which biotechnology activities are: A secondary line of business;Total 2019;253
Companies in which biotechnology activities are: A secondary line of business;Companies;171
Companies in which biotechnology activities are: A secondary line of business;P.A.;37
Companies in which biotechnology activities are: A secondary line of business;Higher Education;43
Companies in which biotechnology activities are: A secondary line of business;PNPI;2
Companies in which biotechnology activities are: A tool necessary for production;Total 2019;461
Companies in which biotechnology activities are: A tool necessary for production;Companies;383
Companies in which biotechnology activities are: A tool necessary for production;P.A.;52
Companies in which biotechnology activities are: A tool necessary for production;Higher Education;21
Companies in which biotechnology activities are: A tool necessary for production;PNPI;5
%Companies by field(s) of ultimate application of biotechnology use: Human health;Total 2019;52
%Companies by field(s) of ultimate application of biotechnology use: Human health;Companies;47
%Companies by field(s) of ultimate application of biotechnology use: Human health;P.A.;77
%Companies by field(s) of ultimate application of biotechnology use: Human health;Higher Education;91
%Companies by field(s) of ultimate application of biotechnology use: Human health;PNPI;62
%Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Total 2019;21
%Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Companies;19
%Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;P.A.;16
%Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Higher Education;68
%Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;PNPI;8
%Companies by field(s) of ultimate application of biotechnology use: Food products;Total 2019;33
%Companies by field(s) of ultimate application of biotechnology use: Food products;Companies;33
%Companies by field(s) of ultimate application of biotechnology use: Food products;P.A.;19
%Companies by field(s) of ultimate application of biotechnology use: Food products;Higher Education;80
%Companies by field(s) of ultimate application of biotechnology use: Food products;PNPI;8
%Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Total 2019;26
%Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Companies;24
%Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;P.A.;20
%Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Higher Education;71
%Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;PNPI;23
%Companies by field(s) of ultimate application of biotechnology use: Environment;Total 2019;18
%Companies by field(s) of ultimate application of biotechnology use: Environment;Companies;15
%Companies by field(s) of ultimate application of biotechnology use: Environment;P.A.;21
%Companies by field(s) of ultimate application of biotechnology use: Environment;Higher Education;74
%Companies by field(s) of ultimate application of biotechnology use: Environment;PNPI;15
%Companies by field(s) of ultimate application of biotechnology use: Industry;Total 2019;16
%Companies by field(s) of ultimate application of biotechnology use: Industry;Companies;13
%Companies by field(s) of ultimate application of biotechnology use: Industry;P.A.;13
%Companies by field(s) of ultimate application of biotechnology use: Industry;Higher Education;70
%Companies by field(s) of ultimate application of biotechnology use: Industry;PNPI;8
Personnel in R&D in biotechnology (no. of persons);Total 2019;43.523
Personnel in R&D in biotechnology (no. of persons);Companies;13.615
Personnel in R&D in biotechnology (no. of persons);P.A.;14.682
Personnel in R&D in biotechnology (no. of persons);Higher Education;15.063
Personnel in R&D in biotechnology (no. of persons);PNPI;163
Personnel in R&D in biotechnology (no. of persons): Researchers;Total 2019;28.702
Personnel in R&D in biotechnology (no. of persons): Researchers;Companies;7.436
Personnel in R&D in biotechnology (no. of persons): Researchers;P.A.;9.191
Personnel in R&D in biotechnology (no. of persons): Researchers;Higher Education;11.968
Personnel in R&D in biotechnology (no. of persons): Researchers;PNPI;107
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Total 2019;14.820
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Companies;6.178
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;P.A.;5.491
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Higher Education;3.095
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;PNPI;56
Personnel in R&D in biotechnology (no. of persons): women;Total 2019;24.516
Personnel in R&D in biotechnology (no. of persons): women;Companies;7.639
Personnel in R&D in biotechnology (no. of persons): women;P.A.;9.277
Personnel in R&D in biotechnology (no. of persons): women;Higher Education;7.494
Personnel in R&D in biotechnology (no. of persons): women;PNPI;106
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Total 2019;15.356
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Companies;4.095
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;P.A.;5.444
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Higher Education;5.753
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;PNPI;64
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Total 2019;9.160
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Companies;3.544
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;P.A.;3.833
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Higher Education;1.741
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;PNPI;42
Personnel in R&D in biotechnology (FTE);Total 2019;29.655,1
Personnel in R&D in biotechnology (FTE);Companies;9.365,2
Personnel in R&D in biotechnology (FTE);P.A.;11.013,2
Personnel in R&D in biotechnology (FTE);Higher Education;9.177,3
Personnel in R&D in biotechnology (FTE);PNPI;99,4
Personnel in R&D in biotechnology (FTE): Researchers;Total 2019;19.150,3
Personnel in R&D in biotechnology (FTE): Researchers;Companies;5.410,6
Personnel in R&D in biotechnology (FTE): Researchers;P.A.;6.546,6
Personnel in R&D in biotechnology (FTE): Researchers;Higher Education;7.128,5
Personnel in R&D in biotechnology (FTE): Researchers;PNPI;64,6
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Total 2019;10.504,8
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Companies;3.954,6
Personnel in R&D in biotechnology (FTE): Technicians and assistants;P.A.;4.466,6
Personnel in R&D in biotechnology (FTE): Technicians and assistants;Higher Education;2.048,8
Personnel in R&D in biotechnology (FTE): Technicians and assistants;PNPI;34,8
Personnel in R&D in biotechnology (FTE): women;Total 2019;16.997,1
Personnel in R&D in biotechnology (FTE): women;Companies;5.385,8
Personnel in R&D in biotechnology (FTE): women;P.A.;6.959,9
Personnel in R&D in biotechnology (FTE): women;Higher Education;4.581,4
Personnel in R&D in biotechnology (FTE): women;PNPI;70
Personnel in R&D in biotechnology (FTE): (women) Researchers;Total 2019;10.349,2
Personnel in R&D in biotechnology (FTE): (women) Researchers;Companies;3.032,9
Personnel in R&D in biotechnology (FTE): (women) Researchers;P.A.;3.876,1
Personnel in R&D in biotechnology (FTE): (women) Researchers;Higher Education;3.397,2
Personnel in R&D in biotechnology (FTE): (women) Researchers;PNPI;43
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Total 2019;6.647,9
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Companies;2.352,9
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;P.A.;3.083,8
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Higher Education;1.184,2
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;PNPI;27
Internal expenditure on R&D (thousands of euros);Total 2019;2.040.323
Internal expenditure on R&D (thousands of euros);Companies;940.230
Internal expenditure on R&D (thousands of euros);P.A.;652.393
Internal expenditure on R&D (thousands of euros);Higher Education;442.089
Internal expenditure on R&D (thousands of euros);PNPI;5.611
1) By nature of the expense: Current expenses;Total 2019;1.899.869
1) By nature of the expense: Current expenses;Companies;871.813
1) By nature of the expense: Current expenses;P.A.;608.579
1) By nature of the expense: Current expenses;Higher Education;413.960
1) By nature of the expense: Current expenses;PNPI;5.517
1.1) Remuneration to researchers;Total 2019;776.880
1.1) Remuneration to researchers;Companies;284.936
1.1) Remuneration to researchers;P.A.;242.168
1.1) Remuneration to researchers;Higher Education;247.973
1.1) Remuneration to researchers;PNPI;1.802
1.2) Remuneration to technicians and assistants;Total 2019;333.017
1.2) Remuneration to technicians and assistants;Companies;148.254
1.2) Remuneration to technicians and assistants;P.A.;118.062
1.2) Remuneration to technicians and assistants;Higher Education;65.769
1.2) Remuneration to technicians and assistants;PNPI;931
1.3) Other current expenses;Total 2019;789.972
1.3) Other current expenses;Companies;438.623
1.3) Other current expenses;P.A.;248.348
1.3) Other current expenses;Higher Education;100.217
1.3) Other current expenses;PNPI;2.784
2) By nature of the expense: Capital expenses;Total 2019;140.454
2) By nature of the expense: Capital expenses;Companies;68.417
2) By nature of the expense: Capital expenses;P.A.;43.814
2) By nature of the expense: Capital expenses;Higher Education;28.129
2) By nature of the expense: Capital expenses;PNPI;94
2.1) Land and buildings;Total 2019;30.677
2.1) Land and buildings;Companies;11.763
2.1) Land and buildings;P.A.;11.874
2.1) Land and buildings;Higher Education;7.040
2.1) Land and buildings;PNPI;0
2.2) Equipment and instruments;Total 2019;90.306
2.2) Equipment and instruments;Companies;39.641
2.2) Equipment and instruments;P.A.;31.009
2.2) Equipment and instruments;Higher Education;19.567
2.2) Equipment and instruments;PNPI;89
2.3) Acquisition of specific R+D software;Total 2019;4.900
2.3) Acquisition of specific R+D software;Companies;2.831
2.3) Acquisition of specific R+D software;P.A.;757
2.3) Acquisition of specific R+D software;Higher Education;1.310
2.3) Acquisition of specific R+D software;PNPI;3
2.4) Otros productos de propiedad intelectual específicos para I+D;Total 2019;14.571
2.4) Otros productos de propiedad intelectual específicos para I+D;Companies;14.183
2.4) Otros productos de propiedad intelectual específicos para I+D;P.A.;173
2.4) Otros productos de propiedad intelectual específicos para I+D;Higher Education;212
2.4) Otros productos de propiedad intelectual específicos para I+D;PNPI;2
1.1) By origin of the funds: Own funds;Total 2019;742.583
1.1) By origin of the funds: Own funds;Companies;577.287
1.1) By origin of the funds: Own funds;P.A.;78.505
1.1) By origin of the funds: Own funds;Higher Education;86.280
1.1) By origin of the funds: Own funds;PNPI;511
1.2) By origin of the funds: From companies;Total 2019;268.227
1.2) By origin of the funds: From companies;Companies;142.672
1.2) By origin of the funds: From companies;P.A.;96.507
1.2) By origin of the funds: From companies;Higher Education;28.164
1.2) By origin of the funds: From companies;PNPI;884
1.3) By origin of the funds: Public Administration funds;Total 2019;783.942
1.3) By origin of the funds: Public Administration funds;Companies;102.630
1.3) By origin of the funds: Public Administration funds;P.A.;396.610
1.3) By origin of the funds: Public Administration funds;Higher Education;282.374
1.3) By origin of the funds: Public Administration funds;PNPI;2.327
1.4) By origin of the funds: From Universities;Total 2019;2.785
1.4) By origin of the funds: From Universities;Companies;457
1.4) By origin of the funds: From Universities;P.A.;1.190
1.4) By origin of the funds: From Universities;Higher Education;1.138
1.4) By origin of the funds: From Universities;PNPI;0
1.5) By origin of the funds: From non profit private institutions;Total 2019;30.232
1.5) By origin of the funds: From non profit private institutions;Companies;9.631
1.5) By origin of the funds: From non profit private institutions;P.A.;13.309
1.5) By origin of the funds: From non profit private institutions;Higher Education;5.740
1.5) By origin of the funds: From non profit private institutions;PNPI;1.553
1.6) By origin of the funds: Foreign funds;Total 2019;212.555
1.6) By origin of the funds: Foreign funds;Companies;107.553
1.6) By origin of the funds: Foreign funds;P.A.;66.273
1.6) By origin of the funds: Foreign funds;Higher Education;38.392
1.6) By origin of the funds: Foreign funds;PNPI;336
Purchase of services R & D in Biotechnology to (thousands of euros);Total 2019;133.151
Purchase of services R & D in Biotechnology to (thousands of euros);Companies;114.839
Purchase of services R & D in Biotechnology to (thousands of euros);P.A.;12.728
Purchase of services R & D in Biotechnology to (thousands of euros);Higher Education;5.216
Purchase of services R & D in Biotechnology to (thousands of euros);PNPI;368
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Total 2019;85.933
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Companies;69.258
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;P.A.;11.630
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Higher Education;4.727
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;PNPI;318
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Total 2019;47.219
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Companies;45.581
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;P.A.;1.098
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Higher Education;489
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;PNPI;51
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Total 2019;44,2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Companies;41,8
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;P.A.;57,4
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Higher Education;56,1
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;PNPI;76,9
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Total 2019;11,3
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Companies;12
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;P.A.;2,5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Higher Education;12,1
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;PNPI;23,1
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Total 2019;16,8
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Companies;13,1
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;P.A.;39,3
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Higher Education;40,9
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;PNPI;30,8
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Total 2019;13,4
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Companies;10,7
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;P.A.;28,7
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Higher Education;33,3
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;PNPI;23,1
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Total 2019;18,1
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Companies;15,1
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;P.A.;32,8
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Higher Education;42,4
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;PNPI;30,8
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Total 2019;18
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Companies;16
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;P.A.;30
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Higher Education;41
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;PNPI;23
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Total 2019;15,2
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Companies;15,9
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;P.A.;9
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Higher Education;10,6
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;PNPI;38,5
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Total 2019;37
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Companies;37
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;P.A.;41
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Higher Education;36
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;PNPI;39
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Total 2019;51,9
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Companies;50,7
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;P.A.;57,4
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Higher Education;63,6
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;PNPI;53,8
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Total 2019;19,1
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Companies;19
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;P.A.;20,5
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Higher Education;16,7
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;PNPI;30,8
%Companies that have requested biotechnology patents in Biotechnology;Total 2019;23,7
%Companies that have requested biotechnology patents in Biotechnology;Companies;18,3
%Companies that have requested biotechnology patents in Biotechnology;P.A.;53,3
%Companies that have requested biotechnology patents in Biotechnology;Higher Education;69,7
%Companies that have requested biotechnology patents in Biotechnology;PNPI;7,7
Number of patents requested;Total 2019;1.846
Number of patents requested;Companies;643
Number of patents requested;P.A.;667
Number of patents requested;Higher Education;535
Number of patents requested;PNPI;1